genedrive plc (FRA:D6M)

Market Cap	10.38M
Revenue (ttm)	1.11M
Net Income (ttm)	-6.10M
Shares Out	n/a
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	1,875
Open	0.0100
Previous Close	0.0085
Day's Range	0.0100 - 0.0100
52-Week Range	0.0005 - 0.0305
Beta	n/a
RSI	47.87
Earnings Date	Dec 31, 2025

About genedrive

genedrive plc engages in the design, development, and manufacture of molecular diagnostics testing equipment for use in genotyping, pathogen detection, infectious disease detection, and other clinical indications. The company provides Genedrive system, rapid nucleic acid thermocycler and fluorescence signal detection system for target discrimination used for qualitative in vitro molecular diagnostic tests; and Genedrive CYP2C19 ID Kit, a certified test for identification of individuals unlikely to respond to the commonly prescribed antiplatelet...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2000
• Employees: 43
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: D6M

Financial Performance

In 2025, genedrive's revenue was 954,000, an increase of 90.42% compared to the previous year's 501,000. Losses were -5.23 million, -26.06% less than in 2024.

Financial numbers in GBP